On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received a pig kidney transplant.

Doctors at Massachusetts General Hospital transplanted a pig kidney into a 66-year-old patient with end-stage kidney disease. The surgical team reported that the new kidney is functioning as expected.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as part of a new clinical trial sanctioned by the Food and Drug Administration. Two of the previous patients died shortly after the procedure, including one who was critically ill before the transplant.

The second person ever has received a transplant with a genetically modified pig kidney.

A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time successfully transplanted a genetically edited pig kidney into a living person. The team performed the first surgery of its kind in the world in March 2024.

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ transplant.

An Alabama grandmother who was the first patient to receive a new kind of genetically modified pig kidney more than two months ago is now the longest surviving recipient of a pig organ.